NITROGEN HETEROCYCLE INHIBITORS OF ASPARTYL PROTEASE

Details for Australian Patent Application No. 2002348473 (hide)

Owner ENANTA PHARMACEUTICALS, INC.

Inventors WANG, Guogiang; OR, Yat, Sun; ROUGAS, John; RIESINGER, Steven

Pub. Number AU-A-2002348473

PCT Number PCT/US02/33527

PCT Pub. Number WO2003/035613

Priority 10/007,342 22.10.01 US

Filing date 18 October 2002

Wipo publication date 6 May 2003

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 10/007,342 22.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002348473

8 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002348474-Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

2002348472-SYSTEM AND METHOD FOR PROVIDING PULSE AMPLITUDE MODULATION FOR OLED DISPLAY DRIVERS